Nearly 20 years ago, scientists stunned the world when they announced they had decoded the genes that make up a human being. As we first reported last March, they hoped to use that genetic blueprint ...
WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
NX-5948 has received fast track designation for relapsed or refractory Waldenström macroglobulinemia after prior BTK inhibitor therapy. The phase 1a/1b trial of NX-5948 shows a 77.8% objective ...
The novel treatment elritercept received a Fast Track designation from the FDA to treat anemia in patients with MDS. For patients with lower-risk myelodysplastic syndromes (MDS), the Food and Drug ...
While mild anemia is generally treatable, some severe forms, like thalassemia and aplastic anemia, can lead to life-threatening complications if untreated due to the body’s organs not receiving enough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback